Chronic Kidney Disease
📧 Sign up to get email alerts when something new happens for Chronic Kidney Disease.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Curcumin on NFE2L2 Gene Expression, Antioxidant Capacity and Renal Function According to rs35652124 in Diabetic Nephropathy [Phase 2, Phase 3]
A Phase 2/3 clinical trial update evaluating curcumin's effects on NFE2L2 gene expression, antioxidant capacity, and renal function in diabe…
-
CLINICAL_TRIALS research · 2018-05-30Clinical Trial Update: Traditional Chinese Medicine (TCM) Colon Dialysis Treats Non-dialysis End-Stage Kidney Disease [Phase 1, Phase 2]
A phase 1/2 clinical trial entry evaluating traditional Chinese medicine–based colon dialysis as a treatment for end-stage kidney disease pa…
-
CLINICAL_TRIALS withdrawal · 2018-05-30Clinical Trial Update: Impact of Screening Patients With HIV for Kidney Disease
The clinical trial evaluating screening HIV patients for kidney disease has been withdrawn.
-
CLINICAL_TRIALS trial_result · 2018-05-25Clinical Trial Update: Study Comparing Treatment Effectiveness of Guideline Indicated APT for ACS in Patients With CKD [Phase 4]
A Phase 4 clinical trial update evaluating the effectiveness of guideline-indicated antiplatelet therapy for acute coronary syndrome in pati…
-
CLINICAL_TRIALS trial_result · 2018-05-23Clinical Trial Update: Study to Assess the Safety and Impact on Humoral Sensitization of SANGUINATE in Patients With End Stage Renal Disease [Phase 1]
Phase 1 trial update reporting safety and the impact on humoral sensitization of SANGUINATE in patients with end-stage renal disease due to …
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2018-05-21Clinical Trial Update: Study to Evaluate the Efficacy, Safety and Pharmacokinetics of Three-times Weekly Dosing of GSK1278863 in Hemodialysis-dependent Subjects With Anemia Associated With Chronic Kidney Disease Who Are Switched From a Stable Dose of an Erythropoiesis-stimulating Agent [Phase 2]
Phase 2 trial evaluating three-times weekly dosing of GSK1278863 in hemodialysis patients with anemia due to chronic kidney disease; study c…
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Extension Study of Cinacalcet for Treatment of Secondary Hyperparathyroidism (SHPT) in Pediatric Patients With Chronic Kidney Disease on Dialysis [Phase 3]
Extension study of cinacalcet for secondary hyperparathyroidism in pediatric CKD patients on dialysis completed; results posted in 2018.
-
CLINICAL_TRIALS trial_result · 2018-05-18Clinical Trial Update: Validation of New Markers of Glomerular Filtration Rate: Dota Gadolinium and Calcium EDTA (MultiGFR) [Phase 1, Phase 2]
This clinical trial update reports termination of Phase 1/2 studies validating new markers of glomerular filtration rate using Dota Gadolini…
-
CLINICAL_TRIALS research · 2018-05-18Clinical Trial Update: Effect of Beraprost Sodium (Berasil) on Hemodialysis [NA]
This document reports a clinical trial update on Beraprost Sodium (Berasil) for improving arteriovenous fistula patency in people undergoing…
-
CLINICAL_TRIALS trial_result · 2018-05-17Clinical Trial Update: Effect of Lactobacillus Rhamnosus on Serum Uremic Toxins in Hemodialysis [NA]
A completed clinical trial evaluating whether supplementation with Lactobacillus rhamnosus alters serum uremic toxin levels in patients unde…
-
FDA approval · 2018-05-15FDA Approved: RETACRIT — Original Application (Vifor (International) Inc.)
The FDA approved Retacrit (epoetin alfa-epbx) under Original Application BLA125545, establishing it as a biosimilar to epoetin alfa. The app…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: A Trial Comparing Ferumoxytol to Iron Sucrose for the Treatment of Iron Deficiency Anemia in Adult Subjects With Chronic Kidney Disease [Phase 2]
Phase 2 trial comparing ferumoxytol with iron sucrose for iron deficiency anemia in adults with chronic kidney disease has completed with re…
-
CLINICAL_TRIALS trial_result · 2018-05-15Clinical Trial Update: Ascorbic Acid on Restenosis of Dysfunctional Hemodialysis Vascular Access [Phase 2]
A Phase 2 clinical trial evaluating ascorbic acid for restenosis in dysfunctional hemodialysis vascular access has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: A Study in Participants With End-Stage Renal Disease [Phase 2]
Phase 2 trial in participants with end-stage renal disease has completed; results were posted on 2018-05-14.
-
CLINICAL_TRIALS trial_result · 2018-05-14Clinical Trial Update: Short-term Metabolic Effects of Ketosteril® Supplemented Low Protein Diet in Pre-dialysis Chronic Kidney Disease (CKD) Patients [Phase 1, Phase 2]
This clinical trial update reports on the short-term metabolic effects of a Ketosteril-supplemented low-protein diet in pre-dialysis chronic…
-
CLINICAL_TRIALS withdrawal · 2018-05-14Clinical Trial Update: Growth Hormone Secretagogue MK-0677's Effect on Lean Body Mass in Chronic Kidney Disease Stage 4/5 Subjects [Phase 2]
A Phase 2 trial evaluating MK-0677 (ibutamoren) for lean body mass in chronic kidney disease stage 4/5 has been withdrawn.
-
CLINICAL_TRIALS research · 2018-05-14Clinical Trial Update: Dynamic Measurement of Renal Functional Reserve as a Predictor of Long-Term Renal Function [NA]
A clinical trial update exploring dynamic measurement of renal functional reserve to predict long-term kidney function, in adults with polyc…
-
CLINICAL_TRIALS research · 2018-05-11Clinical Trial Update: Effects of Exercise and Exercise Counselling in Hemodialysis Patients. [NA]
This entry reports a clinical trial update for a study evaluating the effects of exercise and exercise counselling in patients undergoing he…
-
CLINICAL_TRIALS trial_result · 2018-05-11Clinical Trial Update: Outcome of Total Hip Replacement in Patients With Chronic Renal Disease
The document presents a clinical trial update on the outcomes of total hip replacement in patients with chronic kidney disease, with the tri…
-
CLINICAL_TRIALS withdrawal · 2018-05-09Clinical Trial Update: Chemical Renal Ethanol Sympatholysis Under CT Guidance Use for the Control of Therapy-Resistant Hypertension [Phase 2]
Phase 2 trial evaluating chemical renal sympatholysis with ethanol under CT guidance for therapy-resistant hypertension has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-08Clinical Trial Update: Proof of Concept of Adapted PD in Children (PC-AAPD) [NA]
A completed clinical trial evaluates a proof-of-concept adaptation of peritoneal dialysis in children, assessing key dialysis performance me…
-
CLINICAL_TRIALS withdrawal · 2018-05-08Clinical Trial Update: Discontinuation of Automated Engagement Support [NA]
The University of Vermont-led trial evaluating automated engagement support for Chronic Kidney Disease has been terminated.
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Prevention of Dialysis Catheter Malfunction With Prophylactic Use of a Taurolidine Containing Urokinase [Phase 3]
A Phase 3 trial evaluated a taurolidine-containing urokinase solution to prevent dialysis catheter malfunction and infection; the study has …
-
CLINICAL_TRIALS trial_result · 2018-05-03Clinical Trial Update: Propolis Effects in Patients With Chronic Kidney Disease [Phase 2]
A Phase 2 clinical trial evaluating the effects of propolis in patients with chronic kidney disease has completed.
-
CLINICAL_TRIALS trial_result · 2018-05-02Clinical Trial Update: Effects of a Non-Calcium Based Phosphate Binder on FGF23 Levels in Chronic Kidney Disease [EARLY_Phase 1]
Phase 1 study evaluating a non-calcium based phosphate binder and its effect on FGF23 levels in chronic kidney disease; the trial has comple…